Effect of estrogenic compounds (estrogen or phytoestrogens) combined with exercise on bone and muscle mass in older individuals

Applied Physiology, Nutrition and Metabolism

Volumn 33, Issue 1, 2008, Pages 200-212

  Chilibeck, Philip D ^a   Cornish, Stephen M ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Isoflavone; Lignans; Osteoporosis; Sarcopenia; Secoisolariciresinol diglucoside

Indexed keywords

ESTROGEN; PHYTOESTROGEN;

AGED; AGING; BONE; CONFERENCE PAPER; DRUG EFFECT; EXERCISE; FEMALE; HUMAN; MUSCLE ATROPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

AGED; AGING; BONE AND BONES; ESTROGENS; EXERCISE; FEMALE; HUMANS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; PHYTOESTROGENS;

EID: 39749185927     PISSN: 17155312     EISSN: None     Source Type: Journal    
DOI: 10.1139/H07-140     Document Type: Conference Paper

References (99)

1. 2 production by cultured osteocytes. Am. J. Physiol. 276: E171-E178.
2. Alekel, D.L., St. Germain, S., Petersen, C.T., Hanson, K.B., Stewart, J.W., and Toda, T. 2000. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am. J. Clin. Nutr. 72: 844-852.
3. Atkinson, C., Compston, J.E., Day, N.E., Dowsett, M., and Bingham, S.A. 2004. The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am. J. Clin. Nutr. 79: 326-333.
4. Aubertin-Leheudre, M., Lord, C., Khalil, A., and Dionne, I.J. 2007. Six months of isoflavone supplement increases fat-free mass in obese-sarcopenic postmenopausal women: a randomized double-blind controlled trial. Eur. J. Clin. Nutr. 61: 1442-1444.
5. Bautmans, I., Njemini, R., Vasseur, S., Chabert, H., Moens, L., Demanet, C., and Mets, T. 2005. Biochemical changes in response to intensive resistance exercise training in the elderly. Gerontology, 51: 253-265. doi:10.1159/000085122.
6. Braidman, I.P., Baris, C., Selby, P.L., Adams, J.E., Freemont, A.J., and Hoyland, J.A. 2000. Preliminary report of impaired oestrogen receptor-alpha expression in bone, but no involvement of androgen receptor, in male idiopathic osteoporosis. J. Pathol. 192: 90-96. doi:10.1002/1096-9896(2000)9999: 9999〈::AIDPATH684〉3.0.CO;2-P.
7. Brooks, J.D., Ward, W.E., Lewis, J.E., Hilditch, J., Nickell, L., Wong, E., and Thompson, U. 2004. Supplementation with flax-seed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. Am. J. Clin. Nutr. 79: 318-325.
8. Brown, M., Birge, S.J., and Kohrt, W.M. 1997. Hormone replacement therapy does not augment gains in muscle strength or fat-free mass in response to weight-bearing exercise. J. Gerontol. A Biol. Sci. Med. Sci. 52: B166-B170.
9. Castillo, E.M., Goodman-Gruen, D., Kritz-Silverstein, D., Morton, D.J., Wingard, D.L., and Barrett-Connor, E. 2003. Sarcopenia in elderly men and women: the Rancho Bernardo study. Am. J. Prev. Med. 25: 226-231. doi:10.1016/S0749-3797(03)00197-1.
10. 2+ regulates fluid shear-induced cytoskeletal reorganization and gene expression in osteoblasts. Am. J. Physiol. Cell Physiol. 278: C989-C997.
11. Chen, X., Garner, S.C., Quarles, L.D., and Anderson, J.J. 2003. Effects of genistein on expression of bone markers during MC3T3-E1 osteoblastic cell differentiation. J. Nutr. Biochem. 14: 342-349. doi:10.1016/S0955- 2863(03)00056-1.
12. Chen, Z., Bassford, T., Green, S.B., Cauley, J.A., Jackson, R.D., LaCroix, A.Z., et al. 2005. Postmenopausal hormone therapy and body composition - a substudy of the estrogen plus progestin trial of the Women's Health Initiative. Am. J. Clin. Nutr. 82: 651-656.
13. Cheng, S., Sipila, S., Taaffe, D.R., Puolakka, J., and Suominen, H. 2002a. Change in bone mass distribution induced by hormone replacement therapy and high-impact physical exercise in post-menopausal women. Bone, 31: 126-135. doi:10.1016/S8756-3282(02)00794-9.
14. Cheng, M.Z., Rawlinson, S.C., Pitsillides, A.A., Zaman, G., Mohan, S., Baylink, D.J., and Lanyon, L.E. 2002b. Human osteoblasts' proliferative responses to strain and 17β-estradiol are mediated by the estrogen receptor and the receptor for insulin-like growth factor I. J. Bone Miner. Res. 17: 593-602. doi:10.1359/jbmr.2002.17.4.593.
15. Chilibeck, P.D. 2004. Exercise and estrogen or estrogen alternatives (phytoestrogens, bisphosphonates) for preservation of bone mineral in postmenopausal women. Can. J. Appl. Physiol. 29: 59-75.
16. Chilibeck, P., Calder, A., Sale, D.G., and Webber, C. 1994. Reproducibility of dual-energy x-ray absorptiometry. Can. Assoc. Radiol. J. 45: 297-302.
17. Chilibeck, P.D., Sale, D.G., and Webber, C.E. 1995. Exercise and bone mineral density. Sports Med. 19: 103-122.
18. Chilibeck, P.D., Davison, K.S., Whiting, S.J., Suzuki, Y., Janzen, C.L., and Peloso, P. 2002. The effect of strength training combined with bisphosphonate (etidronate) therapy on bone mineral, lean tissue, and fat mass in postmenopausal women. Can. J. Physiol. Pharmacol. 80: 941-950. doi:10.1139/y02-126.
19. Clifton-Bligh, P.B., Baber, R.J., Fulcher, G.R., Nery, M.L., and Moreton, T. 2001. The effect of isoflavones extracted from red clover (Rimostil) on lipids and bone metabolism. Menopause, 8: 259-265. doi:10.1097/00042192- 200107000-00007.
20. Dalais, F.S., Rice, G.E., Wahlqvist, M.L., Grehan, M., Murkies, A.L., Medley, G., et al. 1998. Effects of dietary phytoestrogens in postmenopausal women. Climacteric, 1: 124-129.
21. Damien, E., Price, J.S., and Lanyon, L.E. 1998. The estrogen receptor's involvement in osteoblasts' adaptive response to mechanical strain. J. Bone Miner. Res. 13: 1275-1282. doi:10.1359/jbmr.1998.13.8.1275.
22. Damien, E., Price, J.S., and Lanyon, L.E. 2000. Mechanical strain stimulates osteoblast proliferation through the estrogen receptor in males as well as females. J. Bone Miner. Res. 15: 2169-2177. doi:10.1359/jbmr. 2000.15.11.2169.
23. Deschenes, M.R. 2004. Effects of aging on muscle fibre type and size. Sports Med. 34: 809-824. doi:10.2165/00007256-200434120-00002.
24. Dodin, S., Lemay, A., Jacques, H., Légaré, F., Forest, J.C., and Mâsse, B. 2005. The effects of flaxseed dietary supplement on lipid profile, bone-mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled trial. J. Clin. Endocrinol. Metab. 90: 1390-1397. doi:10.1210/jc.2004-1148.
25. Ferrucci, L., Penninx, B.W., Volpato, S., Harris, T.B., Bandeen-Roche, K., Balfour, J., et al. 2002. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J. Am. Geriatr. Soc. 50: 1947-1954. doi:10.1046/j.1532-5415.2002. 50605.x.
26. Gambacciani, M., Monteleone, P., Sacco, A., and Genazzani, A.R. 2003. Hormone replacement therapy and endometrial, ovarian and colorectal cancer. Best Pract. Res. Clin. Endocrinol. Metab. 17: 139-147. doi:10.1016/S1521- 690X(02)00086-6.
27. Hartmann, B., Kirchengast, S., Albrecht, A., Laml, T., Bikas, D., and Huber, J. 1995. Effects of hormone replacement therapy on growth hormone secretion patterns in correlation to somatometric parameters in healthy postmenopausal women. Maturitas, 22: 239-246. doi:10.1016/0378-5122(95) 00942-E.
28. Haub, M.D., Wells, A.M., Tarnopolsky, M.A., and Campbell, W.W. 2002. Effect of protein source on resistive-training-induced changes in body composition and muscle size in older men. Am. J. Clin. Nutr. 76: 511-517.
29. Heikkinen, J., Kyllonen, E., Kurttila-Matero, E., Wilen-Rosenqvist, G., Lankinen, K.S., Rita, H., and Vaananen, H.K. 1997. HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women. Maturitas, 26: 139-149. doi:10.1016/S0378-5122(96)01098-5.
30. Huang, Y., Cao, S., Nagamani, M., Anderson, K.E., Grady, J.J., and Lu, L.J. 2005. Decreased circulating levels of tumor necrosis factor-α in postmenopausal women during consumption of soy-containing isoflavones. J. Clin. Endocrinol. Metab. 90: 3956-3962. doi:10.1210/jc.2005-0161.
31. Janssen, I., and Ross, R. 2005. Linking age-related changes in muscle mass and composition with metabolism and disease. J. Nutr. Health Aging, 9: 408-419.
32. Janssen, I., Baumgartner, R.N., Ross, R., Rosenberg, I.H., and Roubenoff, R. 2004a. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am. J. Epidemiol. 159: 413-421. doi:10.1093/aje/kwh058.
33. Janssen, I., Shepard, D.S., Katzmarzyk, P.T., and Roubenoff, R. 2004b. The healthcare costs of sarcopenia in the United States. J. Am. Geriatr. Soc. 52: 80-85. doi:10.1111/j.1532-5415.2004.52014.x.
34. Joo, S.S., Kang, H.C., Lee, M.W., Choi, Y.W., and Lee, D.I. 2003. Inhibition of IL-1β and IL-6 in osteoblast-like cell by isoflavones extracted from Sophorae fructus. Arch. Pharm. Res. 26: 1029-1035.
35. Kenny, A.M., Dawson, L., Kleppinger, A., Iannuzzi-Sucich, M., and Judge, J.O. 2003. Prevalence of sarcopenia and predictors of skeletal muscle mass in nonobese women who are long-term users of estrogen-replacement therapy. J. Gerontol. A Biol. Sci. Med. Sci. 58: M436-M440.
36. Kitts, D.D., Yuan, Y.V., Wijewickreme, A.N., and Thompson, L.U. 1999. Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol. Cell. Biochem. 202: 91-100. doi:10.1023/A:1007022329660.
37. Kohrt, W.M., Snead, D.B., Slatopolsky, E., and Birge, S.J. 1995. Additive effects of weight-bearing exercise and estrogen on bone mineral density in older women. J. Bone Miner. Res. 10: 1303-1311.
38. Kohrt, W.M., Ehsani, A.A., and Birge, S.J. 1998. HRT preserves increases in bone mineral density and reductions in body fat after a supervised exercise program. J. Appl. Physiol. 84: 1506-1512.
39. Kreijkamp-Kaspers, S., Kok, L., Grobbee, D.E., de Haan, E.H., Aleman, A., Lampe, J.W., and van der Schouw, Y.T. 2004. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA, 292: 65-74. doi:10.1001/jama.292.1.65.
40. Kuijsten, A., Arts, I.C., Vree, T.B., and Hollman, P.C. 2005. Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside. J. Nutr. 135: 795-801.
41. Lee, K.C., and Lanyon, L.E. 2004. Mechanical loading influences bone mass through estrogen receptor α. Exerc. Sport Sci. Rev. 32: 64-68. doi:10.1097/00003677-200404000-00005.
42. Lee, K.C., Jessop, H., Suswillo, R., Zaman, G., and Lanyon, L.E. 2004. The adaptive response of bone to mechanical loading in female transgenic mice is deficient in the absence of oestrogen receptor-α and -β. J. Endocrinol. 182: 193-201. doi:10.1677/joe.0.1820193.
43. Lemoine, S., Granier, P., Tiffoche, C., Rannou-Bekono, F., Thieulant, M.L., and Delamarche, P. 2003. Estrogen receptor α mRNA in human skeletal muscle. Med. Sci. Sports Exerc. 35: 439-443. doi:10.1249/01.MSS. 0000053654.14410.78.
44. Li, C.I., Malone, K.E., Porter, P.L., Weiss, N.S., Tang, N.T., Cushing-Haugen, K.L., and Daling, J.R. 2003. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA, 289: 3254-3263. doi:10.1001/jama.289.24.3254.
45. Little, J.P., Cornish, S.M., and Chilibeck, P.D. 2006. The effects of exercise training combined with flaxseed lignan supplementation on body composition in older adults. Appl. Physiol. Nutr. Metabol. 31(Suppl.1): S52 [Abstract].
46. Lorrain, J., Paiement, G., Chevrier, N., Lalumiere, G., Laflamme, G.H., Caron, P., and Fillion, A. 2003. Population demographics and socioeconomic impact of osteoporotic fractures in Canada. Menopause, 10: 228-234. doi:10.1097/00042192-200310030-00010.
47. Maddalozzo, G.F., Cardinal, B.J., Li, F., and Snow, C.M. 2004. The association between hormone therapy use and changes in strength and body composition in early postmenopausal women. Menopause, 11: 438-446. doi:10.1097/01.GME.0000113847.74835.FE.
48. Maesta, N., Nahas, E.A., Nahas-Neto, J., Orsatti, F.L., Fernandes, C.E., Traiman, P., and Burini, R.C. 2007. Effects of soy protein and resistance exercise on body composition and blood lipids in postmenopausal women. Maturitas, 56: 350-358. doi:10.1016/j.maturitas.2006.10.001.
49. Mathey, J., Mardon, J., Fokialakis, N., Puel, C., Kati-Coulibaly, S., Mitakou, S., et al. 2007. Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol. Osteoporos. Int. 18: 671-679. doi:10.1007/s00198-007-0351-y.
50. Milliken, L.A., Going, S.B., Houtkooper, L.B., Flint-Wagner, H.G., Figueroa, A., Metcalfe, L.L., et al. 2003. Effects of exercise training on bone remodelling, insulin-like growth factors, and bone mineral density in postmenopausal women with and without hormone replacement therapy. Calcif. Tissue Int. 72: 478-484. doi:10.1007/s00223-001-1128-5.
51. Moeller, L.E., Peterson, C.T., Hanson, K.B., Dent, S.B., Lewis, D.S., King, D.S., and Alekel, D.L. 2003. Isoflavone-rich soy protein prevents loss of hip lean mass but does not prevent the shift in regional fat distribution in perimenopausal women. Menopause, 10: 322-331. doi:10.1097/01.GME. 0000054763.94658.FD.
52. Morabito, N., Crisfulli, A., Vergara, C., Gaudio, A., Lasco, A., Frisina, N., et al. 2002. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J. Bone Miner. Res. 17: 1904-1912. doi:10.1359/jbmr.2002.17.10. 1904.
53. Morris, C., Thorpe, J., Ambrosio, L., and Santin, M. 2006. The soybean isoflavone genistein induces differentiation of MG63 human osteosarcoma osteoblasts. J. Nutr. 136: 1166-1170.
54. Nakajima, D., Kim, C.S., Oh, T.W., Yang, C.Y., Naka, T., Igawa, S., and Ohta, F. 2001. Suppressive effects of genistein dosage and resistance exercise on bone loss in ovariectomized rats. J. Physiol. Anthropol. Appl. Human Sci. 20: 285-291. doi:10.2114/jpa.20.285.
55. Nikawa, T., Ikemoto, M., Sakai, T., Kano, M., Kitano, T., Kawahara, T., et al. 2002. Effects of a soy protein diet on exercise-induced muscle protein catabolism in rats. Nutrition, 18: 490-495. doi:10.1016/S0899-9007(02) 00744-X.
56. Notelovitz, M., Martin, D., Tesar, R., Khan, F.Y., Probart, C., Fields, C., and McKenzie, L. 1991. Estrogen therapy and variable-resistance weight training increase bone mineral in surgically menopausal women. J. Bone Miner. Res. 6: 583-589.
57. Noyan-Ashraf, M.H., Sadeghinejad, Z., and Juurlink, B.H. 2005. Dietary approach to decrease aging-related CNS inflammation. Nutr. Neurosci. 8: 101-110. doi:10.1080/10284150500069470.
58. Noyan-Ashraf, M.H., Wu, L., Wang, R., and Juurlink, B.H. 2006. Dietary approaches to positively influence fetal determinants of adult health. FASEB J. 20: 371-373.
59. Olszynski, W.P., Davison, K.S., Adachi, J.D., Brown, J.P., Cummings, S.R., Hanley, D.A., et al. 2004. Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment. Clin. Ther. 26: 15-28. doi:10.1016/S0149- 2918(04)90002-1.
60. Payette, H., Roubenoff, R., Jacques, J.F., Dinarello, C.A., Wilson, P.W., Abad, L.W., and Harris, T. 2003. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study. J. Am. Geriatr. Soc. 51: 1237-1243. doi:10.1046/j.1532-5415. 2003.51407.x.
61. Phillips, S.K., Rook, K.M., Siddle, N.C., Bruce, S.A., and Woledge, R.C. 1993. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin. Sci. (London), 84: 95-98.
62. Porter, M.M., Vandervoort, A.A., and Lexell, J. 1995. Aging of human muscle: structure, function, and adaptability. Scand. J. Med. Sci. Sports, 5: 129-142.
63. Potter, S.M., Baum, J.A., Teng, H., Stillman, R.J., Shay, N.F., and Erdman, J.W. 1998. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am. J. Clin. Nutr. 68(Suppl): 1375S-1379S.
64. Prasad, K. 1997. Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flax-seed. Mol. Cell. Biochem. 168: 117-123. doi:10.1023/A:1006847310741.
65. Prasad, K. 2000a. Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int. J. Angiol. 9: 220-225. doi:10.1007/BF01623898.
66. Prasad, K. 2000b. Oxidative stress as a mechanism of diabetes in diabetic BB prone rats: effect of secoisolariciresinol diglucoside (SDG). Mol. Cell. Biochem. 209: 89-96. doi:10.1023/A:1007079802459.
67. Prince, R.L., Smith, M., Dick, I.M., Price, R.I., Webb, P.G., Henderson, N.K., and Harris, M.M. 1991. Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy. N. Engl. J. Med. 325: 1189-1195.
68. Register, T.C., Cann, J.A., Kaplan, J.R., Williams, J.K., Adams, M.R., Anthony, M.S., et al. 2005. Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys. J. Clin. Endocrinol. Metab. 90: 1734-1740. doi:10.1210/jc.2004-0939.
69. Reinwald, S., and Weaver, C.M. 2006. Soy isoflavones and bone health: a double-edged sword? J. Nat. Prod. 69: 450-459. doi:10.1021/np058104g.
70. Rickard, D.J., Monroe, D.G., Ruesink, T.J., Khosla, S., Riggs, B.L., and Spelsberg, T.C. 2003. Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors α and β. J. Cell. Biochem. 89: 633-646. doi:10.1002/jcb.10539.
71. Riggs, B.L., and Melton, L.J. 1992. The prevention and treatment of osteoporosis. N. Engl. J. Med. 327: 620-627.
72. Riggs, B.L., Khosla, S., and Melton, L.J. 2002. Sex steroids and the construction and conservation of the adult skeleton. Endocr. Rev. 23: 279-302. doi:10.1210/er.23.3.279.
73. Roubenoff, R. 2001. Origins and clinical relevance of sarcopenia. Can. J. Appl. Physiol. 26: 78-89.
74. Roubenoff, R. 2003. Catabolism of aging: is it an inflammatory process? Curr. Opin. Clin. Nutr. Metab. Care, 6: 295-299. doi:10.1097/00075197- 200305000-00005.
75. Ryan-Borchers, T.A., Park, J.S., Chew, B.P., McGuire, M.K., Fournier, L.R., and Beerman, K.A. 2006. Soy isoflavones modulated immune function in healthy postmenopausal women. Am. J. Clin. Nutr. 83: 1118-1125.
76. Saxon, L.K., and Turner, C.H. 2005. Estrogen receptor β: the anti-mechanostat? Bone, 36: 185-192. doi:10.1016/j.bone.2004.08.003.
77. Saxon, L.K., Robling, A.G., Castillo, A.B., Mohan, S., and Tuner, C.H. 2007. The skeletal responsiveness to mechanical loading is enhanced in mice with a null mutation in estrogen receptor β. Am. J. Physiol. Endocrinol. Metab. 293: E484-E491. doi:10.1152/ajpendo.00189.2007.
78. Schaap, L.A., Pluijm, S.M., Deeg, D.J., and Visser, M. 2006. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am. J. Med. 119: 9-17. doi:10.1016/j.amjmed.2005.10.049.
79. Setchell, K.D., and Lydeking-Olsen, E. 2003. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am. J. Clin. Nutr. 78(Suppl.): 593S-609S.
80. Sipila, S., Taaffe, D.R., Cheng, S., Puolakka, J., Toivanen, J., and Suominen, H. 2001. Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in postmenopausal women: a randomized placebo-controlled study. Clin. Sci. (Lond.), 101: 147-157.
81. Skelton, D.A., Phillips, S.K., Bruce, S.A., Naylor, C.H., and Woledge, R.C. 1999. Hormone replacement therapy increases isometric muscle strength of adductor pollicis in post-menopausal women. Clin. Sci. (Lond.), 96: 357-364.
82. Sowers, M., Zheng, H., Tomey, K., Karvonen-Gutierrez, G., Jannausch, M., Li, X., et al. 2007. Changes in body composition in women over six years at mid-life: ovarian and chronological aging. J. Clin. Endocrinol. Metab. 92: 895-901. doi:10.1210/jc.2006-1393.
83. Taaffe, D.R., Newman, A.B., Haggerty, C.L., Colbert, L.H., de Rekeneire, N., Visser, M., et al. 2005. Estrogen replacement, muscle composition, and physical function: the Health ABC Study. Med. Sci. Sports Exerc. 37: 1741-1747. doi:10.1249/01.mss.0000181678.28092.31.
84. Teixeira, P.J., Going, S.B., Houtkooper, L.B., Metcalfe, L.L., Blew, R.M., Flint-Wagner, H.G., et al. 2003. Resistance training in postmenopausal women with and without hormone therapy. Med. Sci. Sports Exerc. 35: 555-562. doi:10.1249/01.MSS.0000058437.17262.11.
85. Vatanparast, H., and Chilibeck, P.D. 2007. Brief critical review: does the effect of soy phytoestrogens on bone in postmenopausal women depend on the equol producing phenotype? Nutr. Rev. 65: 294-299. doi:10.1301/nr.2007. jun.294-299.
86. Viereck, V., Grundker, C., Blaschke, S., Siggelkow, H., Emons, G., and Hofbauer, L.C. 2002. Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts. J. Cell. Biochem. 84: 725-735. doi:10.1002/jcb.10087.
87. Villareal, D.T., Binder, E.F., Yarasheski, K.E., Williams, D.B., Brown, M., Sinacore, D.R., and Kohrt, W.M. 2003. Effects of exercise training added to ongoing hormone replacement therapy on bone mineral density in frail elderly women. J. Am. Geriatr. Soc. 51: 985-990. doi:10.1046/j.1365-2389.2003. 51312.x.
88. Wang, W., Liu, L.Q., Higuchi, C.M., and Chen, H. 1998. Induction of NADPH:quinone reductase by dietary phytoestrogens in colonic Colo205 cells. Biochem. Pharmacol. 56: 189-195. doi:10.1016/S0006-2952(98)00141-5.
89. Ward, W.E., Yuan, Y.V., Cheung, A.M., and Thompson, L.U. 2001a. Exposure to purified lignan from flaxseed (Linum usitatissimum) alters bone development in female rats. Br. J. Nutr. 86: 499-505.
90. Ward, W.E., Yuan, Y.V., Cheung, A.M., and Thompson, L.U. 2001b. Exposure to flaxseed and its purified lignan reduces bone strength in young but not older male rats. J. Toxicol. Environ. Health A, 63: 53-65. doi:10.1080/152873901750128362.
91. Weaver, C.M., and Cheong, J.M. 2005. Soy isoflavones and bone health: the relationship is still unclear. J. Nutr. 135: 1243-1247.
92. Weiderpass, E., Adami, H.O., Baron, J.A., Magnusson, C., Bergstrom, R., Lindgren, A., et al. 1999. Risk of endometrial cancer following estrogen replacement with and without progestins. J. Natl. Cancer Inst. 91: 1131-1137. doi:10.1093/jnci/91.13.1131.
93. Writing Group for the Women's Health Initiative Investigators 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA, 288: 321-333. doi:10.1001/jama.288.3.321.
94. Wu, J., Wang, X.X., Takasaki, M., Ohta, A., Higuchi, M., and Ishimi, Y. 2001. Cooperative effects of exercise training and genistein administration on bone mass in ovariectomized mice. J. Bone Miner. Res. 16: 1829-1836. doi:10.1359/jbmr.2001.16.10.1829.
95. Wu, J., Wang, X.X., Chiba, H., Higuchi, M., Takasaki, M., Ohta, A., and Ishimi, Y. 2003. Combined intervention of exercise and genistein prevented androgen deficiency-induced bone loss in mice. J. Appl. Physiol. 94: 335-342.
96. Wu, J., Wang, X., Chiba, H., Higuchi, M., Nakatani, T., Ezaki, O., et al. 2004. Combined intervention of soy isoflavone and moderate exercise prevents body fat elevation and bone loss in ovari-ectomized mice. Metabolism, 53: 942-948. doi:10.1016/j.metabol.2004.01.019.
97. Wu, J., Oka, J., Tabata, I., and Higuchi, M. 2006. Effects of isoflavone and exercise onf BMD and fat mass in postmenopausal Japanese women: a 1-year randomized placebo-controlled trial. J. Bone Miner. Res. 21: 780-789. doi:10.1359/jbmr.060208.
98. Wu, J., Oka, J., Ezaki, J., Ohtomo, T., Ueno, T., Uchiyama, S., et al. 2007. Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial. Menopause, 14: 866-874.
99. Yu, Z., Li, W., and Zhang, L. 2004. Effects of genistein on cell proliferation and differentiation in human osteoblasts. Wei Sheng Yan Jiu 33: 569-571.